A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal Function

Clinical trial NCT07763418 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07763418
Sponsor: Bristol-Myers Squibb
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Kidney Failure, Chronic

Start date: 2026-08-24
Primary completion: 2026-12-14
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.